首页> 外文期刊>Ancient Science of Life >A clinical Study on the use of Puskara Mooladi Choorna in Tamaka Shvasa (Bronchial Asthma) with pulmonary function tests
【24h】

A clinical Study on the use of Puskara Mooladi Choorna in Tamaka Shvasa (Bronchial Asthma) with pulmonary function tests

机译:Puskara Mooladi Choorna在Tamaka Shvasa(支气管哮喘)中使用肺功能测试的临床研究

获取原文
           

摘要

Tamaka Shvasa which has been mentioned in Ayurvedic classics shares multiple similarities with Bronchial Asthma. Symptom of breathlessness is the main complaint in Bronchial Asthma which can be assessed objectively by Pulmonary Function Test (PFT).The assessment of respiratory function is now a routine part of clinical practice. The expiratory flow rates- Forced Expiratory Volume in first second (FEV), Forced Vital Capacity (FVC) and Peak Expiratory Flow Rate (PEFR) are assessed by an Electronic Spirometer (Kent, England). Six weeks treatment with a compound preparation of herbs including - Sati (Hedichum spicatum, Rose), Puskaramoola (Innula racemosa, Linn), and Amalaki (Emblica officinalis, Gaertn) powder showed a significant effect of increase in Pulmonary Function values. The mean grade score plus standard deviation before trial of FEV, FVC, and PEFR were 62.6±15.06, 2.03±o.53 and 189±44.05 respectively. After six weeks of treatment with Puskaramooladi choorna FEV, FVC and PEFR showed highly significant results with values 63.45±15.9, 2.81±0.33 and 199.6±41.58 respectively. Puskaramooladi choorna can be used as one of the potent medicine in the treatment of the Bronchial Asthma.
机译:阿育吠陀经典中曾提及的Tamaka Shvasa与支气管哮喘有许多相似之处。呼吸困难的症状是支气管哮喘的主要症状,可通过肺功能测试(PFT)进行客观评估。呼吸功能的评估现已成为临床实践的常规内容。呼气流速-第一秒钟的强制呼气量(FEV),强制肺活量(FVC)和峰值呼气流速(PEFR)由电子肺量计(Kent,England)进行评估。用包括Sati(Sed(Hedichum spicatum,Rose),Puskaramoola(Innula racemosa,Linn)和Amalaki(Emblica officinalis,Gaertn)的复合制剂治疗六周显示出明显的肺功能增高效果。 FEV,FVC和PEFR试验前的平均成绩加标准差分别为62.6±15.06、2.03±o.53和189±44.05。用Puskaramooladi choorna FEV治疗6周后,FVC和PEFR显示出非常显着的结果,分别为63.45±15.9、2.81±0.33和199.6±41.58。 Puskaramooladi choorna可用作治疗支气管哮喘的有效药物之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号